Inspire Medical Systems IncProjected 8% sales decline over next 12 months indicates weak end-customer demand.
StockStory highlights OSI Systems as a Russell 2000 stock to target this week, citing its 10.9% annual revenue growth over the last two years and 14.5% annual earnings per share growth over five years, while flagging Sabre and Inspire Medical Systems as facing challenges. Sabre is weighed down by sluggish total bookings, cash burn, and a high net-debt-to-EBITDA ratio of 7 times, while Inspire Medical contends with a smaller revenue base of 915.2 million dollars and a projected 8% sales decline over the next 12 months. OSI Systems, with a market cap of 3.81 billion dollars, trades at 20 times forward price-to-earnings, compared to Sabre at 7.1 times forward enterprise-value-to-EBITDA and Inspire Medical at 49.1 times forward price-to-earnings.
Inspire Medical Systems IncProjected 8% sales decline over next 12 months indicates weak end-customer demand.
OSI Systems IncHighlighted as a Russell 2000 buy with strong revenue and EPS growth, and reasonable valuation.
Sabre CorpoSluggish total bookings and cash burn indicate weak demand for its services.